Enterprise Value
3.28M
Cash
2.785M
Avg Qtr Burn
-7.094M
Short % of Float
0.25%
Insider Ownership
3.41%
Institutional Own.
1.04%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Twirla (levonorgestrel and ethinyl estradiol) transdermal system Details Contraceptive, Progestin and estrogen contraception | Approved Quarterly sales | |
AG890 Details Contraceptive, Progestin-only contraception | Phase 2 Update |